My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 136

    1.

    Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody.

    Martin PJ, Shulman HM, Schubach WH, Hansen JA, Fefer A, Miller G, Thomas ED.

    Ann Intern Med. 1984 Sep;101(3):310-5.PMID: 6087703 [PubMed - indexed for MEDLINE]Related articles

    2.

    Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study.

    Simon M, Bartram CR, Friedrich W, Arnold R, Schmeiser T, Hampl W, Müller-Hermelink HK, Heymer B.

    Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(5):307-19.PMID: 1685038 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Immunoblastic lymphoma after bone marrow graft. Apropos of a case treated by OKT3 monoclonal antibodies for an acute graft versus host reaction]

    Faure P, d'Agay MF, Tricot G, Gluckman E, Brocheriou C.

    Ann Pathol. 1986;6(2):137-43. French. PMID: 3015160 [PubMed - indexed for MEDLINE]Related articles

    4.

    Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.

    Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S.

    Am J Hematol. 2003 Apr;72(4):255-8.PMID: 12666136 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation.

    Blanche S, Le Deist F, Veber F, Lenoir G, Fischer AM, Brochier J, Boucheix C, Delaage M, Griscelli C, Fischer A.

    Ann Intern Med. 1988 Feb;108(2):199-203.PMID: 2829673 [PubMed - indexed for MEDLINE]Related articles

    6.

    Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

    Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C, et al.

    N Engl J Med. 1991 May 23;324(21):1451-6.PMID: 2023604 [PubMed - indexed for MEDLINE]Related articles

    7.

    Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease.

    Claviez A, Tiemann M, Wagner HJ, Dreger P, Suttorp M.

    Pediatr Transplant. 2000 May;4(2):151-5.PMID: 11272609 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia]

    Yago K, Itoh M, Shimada H.

    Rinsho Ketsueki. 2001 Nov;42(11):1105-10. Japanese. PMID: 11808079 [PubMed - indexed for MEDLINE]Related articles

    9.

    Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.

    Kontny U, Boppana S, Jung A, Goebel H, Strahm B, Peters A, Dormann S, Werner M, Bader P, Fisch P, Niemeyer C.

    Haematologica. 2005 Nov;90 Suppl:ECR27.PMID: 16266918 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation.

    Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, et al.

    Blood. 1988 May;71(5):1234-43.PMID: 2833957 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

    Benkerrou M, Jais JP, Leblond V, Durandy A, Sutton L, Bordigoni P, Garnier JL, Le Bidois J, Le Deist F, Blanche S, Fischer A.

    Blood. 1998 Nov 1;92(9):3137-47.PMID: 9787149 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.

    Chiang KY, Hazlett LJ, Godder KT, Abhyankar SH, Christiansen NP, van Rhee F, Lee CG, Bridges K, Parrish RS, Henslee-Downey PJ.

    Bone Marrow Transplant. 2001 Dec;28(12):1117-23.PMID: 11803352 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Late relapse of acute myelogenous leukemia followed by epstein-barr virus-associated lymphoproliferative disease 11 years after allogeneic bone marrow transplantation.

    Kikushige Y, Takase K, Miyamoto T, Numata A, Kamesaki K, Fukuda T, Nagafuji K, Gondo H, Harada M.

    Int J Hematol. 2006 Dec;84(5):441-4.PMID: 17189227 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation.

    Cavazzana-Calvo M, Bensoussan D, Jabado N, Haddad E, Yvon E, Moskwa M, Tachet des Combes A, Buisson M, Morand P, Virion JM, Le Deist F, Fischer A.

    Br J Haematol. 1998 Nov;103(2):543-51.PMID: 9827933 [PubMed - indexed for MEDLINE]Related articles

    15.

    Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.

    Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW.

    Arch Pathol Lab Med. 1998 Aug;122(8):708-14.PMID: 9701332 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies.

    Martin PJ, Hansen JA, Anasetti C, Zutter M, Durnam D, Storb R, Thomas ED.

    Am J Kidney Dis. 1988 Feb;11(2):149-52.PMID: 3277406 [PubMed - indexed for MEDLINE]Related articles

    17.

    T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.

    Coles RE, Boyle TJ, DiMaio JM, Berend KR, Via DF, Lyerly HK.

    Ann Surg Oncol. 1994 Sep;1(5):405-10.PMID: 7531601 [PubMed - indexed for MEDLINE]Related articles

    18.

    Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.

    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.

    Cancer Res. 1981 Nov;41(11 Pt 1):4253-61.PMID: 6272971 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.

    McGuirk JP, Seropian S, Howe G, Smith B, Stoddart L, Cooper DL.

    Bone Marrow Transplant. 1999 Dec;24(11):1253-8.PMID: 10642818 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

    Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, et al.

    N Engl J Med. 1994 Apr 28;330(17):1185-91.PMID: 8093146 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity